Garry Menzel
Board Member
Adaptimmune Therapeutics PLC (ADAPY)Equibles does not estimate personal net worth.
Get an email with a short summary when Adaptimmune Therapeutics PLC publishes a filing, an earnings call transcript or a press release.
Get ADAPY alertsAbout Garry Menzel
Garry Menzel is recorded as Board Member at Adaptimmune Therapeutics PLC (ADAPY). The newest filing on record that lists Garry Menzel as Board Member at Adaptimmune Therapeutics PLC (ADAPY) is dated April 25, 2025. Adaptimmune Therapeutics PLC reported in an 8-K filed June 1, 2023 that Garry Menzel was appointed non-executive director and to serve as a member of the Board's Audit Committee, effective June 1, 2023. Adaptimmune Therapeutics PLC is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Adaptimmune Therapeutics PLC includes Adrian Rawcliffe (CEO and Board Member), David M. Mott (Chairman), Christopher Hill (CFO) and 7 others.
“The board of directors ("Board") of Adaptimmune Therapeutics plc ("Company") is pleased that you have agreed to join the Board as a non-executive director and to serve as a member of the Board's Audit Committee with effect from 1 June 2023.”
Affiliation history
-
Current
Start not stated–present
Last confirmed April 25, 2025
Company network
Leadership on record at Adaptimmune Therapeutics PLC
- Adrian Rawcliffe CEO, Board Member
- David M. Mott Chairman
- Christopher Hill CFO
- William Bertrand COO
- Ali Behbahani Board Member
- Andrew Allen Board Member
- Andrew Allen, MD, PhD Board Member
- Andrew R. Allen Board Member
- Dr Priti Hegde Board Member
- Garry E. Menzel Board Member